International Biotechnology (LON:IBT) Shares Cross Above 200 Day Moving Average - Here's Why

Shares of International Biotechnology (LON:IBT - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 902.08 and traded as high as GBX 974. International Biotechnology shares last traded at GBX 962, with a volume of 35,427 shares traded.International Biotechnology Stock Up 0.6%The company has a market cap of £306.91 million, a price-to-earnings ratio of -292.40 and a beta of 0.49. The stock has a fifty day moving average price of GBX 910.04 and a two-hundred day moving average price of GBX 902.08. About International Biotechnology (Get Free Report)The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.Featured ArticlesFive stocks we like better than International BiotechnologyThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in International Biotechnology Right Now?Before you consider International Biotechnology, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.While International Biotechnology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here